In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Verona Pharma Plc ADR (NASDAQ: VRNA) closed at $67.44 in the last session, down -0.08% from day before closing price of $67.50. In other words, the price has decreased by -$0.08 from its previous closing price. On the day, 1.3 million shares were traded.
Ratios:
We take a closer look at VRNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.48 and its Current Ratio is at 10.63. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $68.
On October 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 05 ’24 when ZACCARDELLI DAVID sold 640,264 shares for $5.01 per share. The transaction valued at 3,205,226 led to the insider holds 14,367,552 shares of the business.
ZACCARDELLI DAVID sold 162,800 shares of VRNA for $815,400 on Dec 06 ’24. The President and CEO now owns 14,204,752 shares after completing the transaction at $5.01 per share. On Dec 04 ’24, another insider, ZACCARDELLI DAVID, who serves as the President and CEO of the company, sold 67,608 shares for $5.00 each. As a result, the insider received 338,162 and left with 15,007,816 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 135.90 while its Price-to-Book (P/B) ratio in mrq is 27.90.
Stock Price History:
Over the past 52 weeks, VRNA has reached a high of $70.40, while it has fallen to a 52-week low of $11.39. The 50-Day Moving Average of the stock is 21.17%, while the 200-Day Moving Average is calculated to be 98.19%.
Shares Statistics:
A total of 84.63M shares are outstanding, with a floating share count of 72.66M. Insiders hold about 14.14% of the company’s shares, while institutions hold 69.63% stake in the company.
